InfuSystem Holdings (INFU) Non-Current Assets (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Non-Current Assets came in at $62.0 million in Q1 2026, down 10.1% YoY from $69.0 million in Q1 2025, and down 3.47% on a QoQ basis from $64.2 million in Q4 2025.
InfuSystem Holdings (INFU) Non-Current Assets (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Non-Current Assets data on file, last reported at $62.0 million in Q1 2026.
- Quarterly Non-Current Assets fell 10.1% year-over-year to $62.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $255.6 million (down 11.17% YoY) and the FY2025 annual result came in at $64.2 million, down 10.11% from the prior year.
- Non-Current Assets retreated to $62.0 million in Q1 2026, from $64.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $75.9 million in Q2 2022 to a low of $62.0 million in Q1 2026.
- A 5-year average of $71.2 million and a median of $72.4 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets advanced 11.74% — and 2025, when it declined 12.65%.
- Tracing INFU's Non-Current Assets over 5 years: stood at $74.6 million in 2022, then retreated by 3.1% to $72.3 million in 2023, then fell by 1.17% to $71.4 million in 2024, then slipped by 10.11% to $64.2 million in 2025, then decreased by 3.47% to $62.0 million in 2026.
- The last three Non-Current Assets figures came in at $62.0 million (Q1 2026), $64.2 million (Q4 2025), and $63.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 59.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.43 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 64.22 Mn |
| Sep 30, 2025 | 63.31 Mn |
| Jun 30, 2025 | 66.05 Mn |
| Mar 31, 2025 | 68.96 Mn |
| Dec 31, 2024 | 71.45 Mn |
| Sep 30, 2024 | 71.69 Mn |
| Jun 30, 2024 | 75.61 Mn |
| Mar 31, 2024 | 72.39 Mn |
| Dec 31, 2023 | 72.30 Mn |
| Sep 30, 2023 | 72.35 Mn |
| Jun 30, 2023 | 74.12 Mn |
| Mar 31, 2023 | 74.34 Mn |
| Dec 31, 2022 | 74.61 Mn |
| Sep 30, 2022 | 75.33 Mn |
| Jun 30, 2022 | 75.86 Mn |
| Mar 31, 2022 | 74.98 Mn |
| Dec 31, 2021 | 75.52 Mn |
| Sep 30, 2021 | 72.92 Mn |